Vivoryon Therapeutics NV Sustainability Reports
Vivoryon Therapeutics N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small molecule medications. The company specializes in modulating the activity and stability of pathologically relevant proteins to treat inflammatory, fibrotic, and age-related diseases such as diabetic kidney disease.
Sector: Professional & technical services
Country: Germany
Exchange: Euronext Amsterdam
LEI: 3912004AMB0KGZXZYJ15
FIGI: BBG001SQY3Y8
16 reports from 2014 to 2025
